학술논문

Evaluation of telephone genetic counselling to facilitate germline BRCA1/2testing in women with high-grade serous ovarian cancer
Document Type
Article
Source
European Journal of Human Genetics: EJHG; August 2019, Vol. 27 Issue: 8 p1186-1196, 11p
Subject
Language
ISSN
10184813; 14765438
Abstract
Systemic healthcare issues and geographical challenges restrict women’s access to BRCA1/2testing to inform the use of tailored treatments for high-grade serous ovarian cancer. Consequently, BRCA1/2testing in this population is low and improved testing pathways are urgently needed. This study aimed to determine the acceptability and feasibility of telephone genetic counselling (TGC) to facilitate treatment-focused BRCA1/2testing in Australia for women with high-grade serous ovarian cancer. Women who received TGC were invited to complete a survey examining their experiences of the service. A cost analysis was conducted to compare the service to standard, in-person genetic counselling. One hundred and seven women responded (48% response rate); 8 had a BRCA1/2variant affecting function. Geographical barriers prevented women from accessing genetic services in the past. All participants had a positive attitude towards testing, and regret following testing was minimal. While the impact of testing was greater for those with a positive test result, overall, genetic testing did not put the additional psychosocial burden on the participants. Participant’s evaluations of the telephone interactions with the genetic counsellors were highly satisfactory. The service was also found to be cost-effective. This model of telephone genetic counselling was an acceptable and effective way to reduce barriers to BRCA1/2testing for women with ovarian cancer.